Niemann-Pick disease

Current Opinion in Hematology

Volumn 7, Issue 1, 2000, Pages 48-52

  Kolodny, Edwin H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN D; PROTEIN DERIVATIVE; SPHINGOMYELIN; SPHINGOSYLPHOSPHORYLCHOLINE;

APOPTOSIS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE CLASSIFICATION; ENZYME THERAPY; GENETIC TRANSFECTION; HUMAN; NIEMANN PICK DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARRIER PROTEINS; CHOLESTEROL, LDL; HUMANS; MEMBRANE GLYCOPROTEINS; NIEMANN-PICK DISEASES; PROTEINS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS;

EID: 0033988606     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200001000-00009     Document Type: Review

References (32)

1. 1 Erlich S, Miranda SRP, Visser JWM, Dagan A, Gatt S, Schuchman EH: Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures. Blood 1999, 93:80-86. The engraftment of transduced stem cells used in gene therapies for NPD is improved by a nontoxic fluorescence-based selection method that relies on enzymatic expression of ASM.
2. 2 Rodriguez-Lafrasse C, Vanier MT: Sphingosyl phosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not type B. Neurochem Res 1999, 24:199-205. Lysosphingolipids are suspected as offending metabolites in the brain of patients with sphingolipid storage diseases.
3. 3 Pavlu H, Elleder M: Two novel mutations in patients with atypical phenotypes of acid sphingomyelinase deficiency. J Inherit Metab Dis 1997, 20:615-616.
4. 4 Obenberger J, Seidl Z, Pavlu H, Elleder M: MRI in an unusually protracted neuronopathic variant of acid sphingomyelinase deficiency. Neuroradiology 1999, 41:182-184.
5. 5 Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, et al.: Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 1997, 277:228-231.
6. 6 Lossos A, Schlesinger I, Okon E, Abramsky O, Bargal R, Vanier MT, Zeigler M: Adult-onset Niemann-Pick Type C disease: clinical, biochemical and genetic study. Arch Neurol 1997, 54:1536-1541.
7. 3097→ T transversion in NPC 1. Am J Hum Genet 1998, 63:52-54. This article describes molecular characterization of the Nova Scotia form of NPD as an allelic variant of NPC-1.
8. 8 Couce ME, Parisi JE, Schochet SS Jr: Adult-onset Niemann-Pick disease type C: a report of two cases. J Neuropathol Exp Neurol 1997, 56:622.
9. 9 Fensom AH, Grant AR, Steinberg SJ, Ward CP, Lake BD, Logan EC, Hulman G: An adult with a non-neuronopathic form of Niemann-Pick C disease. J Inherit Metab Dis 1999, 22:84-86.
10. 10 Jan MMS, Camfield PR: Nova Scotia Niemann-Pick disease (Type D): clinical study of 20 cases. J Child Neurol 1998, 13:75-78. Phenotypic variability in a large series of children with the type D variant of NPD occurs in spite of a single genetic defect.
11. 11 Greer WL, Riddell DC, Byers DM, Welch JP, Girouard GS, Sparrow SM, et al.: Linkage of Niemann-Pick disease type D to the same region of human chromosome 18 as Niemann-Pick disease type C. Am J Hum Genet 1997, 61:139-142.
12. 12 Schofer O, Mischo B, Puschel W, Harzer K, Vanier MT: Early-lethal pulmonary form of Niemann-Pick type C disease belonging to a second, rare genetic complementation group. Eur J Pediatr 1998, 157:45-49. The phenotypic appearance of a second complementation group of NP-C is described.
13. 13 Steinberg SJ, Mondal D, Fensom AH: Co-cultivation of Niemann-Pick disease type C fibroblasts belonging to complementation groups α and β stimulates LDL-derived cholesterol esterification. J Inherit Metab Dis 1996, 19: 769-774.
14. 14 Shamburek RD, Pentchev PG, Zech LA, Blanchette-Mackie J, Carstea ED, VandenBroek JM, et al.: Intracellular trafficking of the free cholesterol derived from LDL cholesteryl ester is defective in vivo in Niemann-Pick C disease: insights on normal metabolism of HDL and LDL gained from the NP-C mutation. J Lipid Res 1997, 38:2422-2435.
15. 15 Patel SC, Suresh S, Kumar U, Hu CY, Cooney A, Blanchette EJ, et al.: Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann-Pick type C disease. Proc Natl Acad Sci U S A 1999, 96:1657-1662. The localization of the NPC-1 protein to astrocytic processes supports a role for mutant NPC-1 protein in the pathogenesis of NP-C.
16. 16 Suzuki K, Parken CC, Pentchev PG: Niemann-Pick disease type C: neuropathology revisited. Dev Brain Dysfunction 1997, 10:306-320.
17. 17 Neufeld EB, Wastney M, Patel S, Sundar S, Cooney AM, Dwyer NK, et al.: The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem 1999, 274:9627-9635. A generalized defect in retrograde vesicular transport from lysosomes to endosomal compartments in NP-C is proposed.
18. 18 Vanier MT: Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem Res 1999, 24:481-489.
19. 2 ganglioside in fibroblasts from a patient with juvenile Niemann-Pick disease type C. Brain Dev 1998, 20:95-97.
20. 20 Hinkouska-Galcheua V, Kjeldseu L, Mansfield PJ, Boxer LA, Shayman JA, Suchard SJ: Activation of a plasma membrane-associated neutral sphingomyelinase and concomitant ceramide accumulation during IgG-dependent phagocytosis in human polymorphonuclear leukocytes. Blood 1998, 91:4761-4769.
21. 21 Langmann T, Buechler C, Ries S, Schaeffler A, Aslanides C, Schuierer M, et al.: Transcription factors Spl and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation. J Lipid Res 1999, 40:870-880.
22. 22 Simon CG Jr, Chatterjee S, Gear AR: Sphingomyelinase activity in human platelets. Thromb Res 1998, 90:155-167.
23. 23 Levade T, Jaffrezou J-P: Signalling Sphingomyelinase: which, where, how and why? Biochim Biophys Acta 1999, 1438:1-7. This is a comprehensive review of signaling sphingomyelinases and how they are regulated. The specific role of the acid sphinomyelinases is examined and studies involving NPD type A cells are tabulated.
24. 24 Grassme H, Gulbins E, Brenner B, Ferlinz K, Sandhoff K, Harzer K, et al.: Acidic Sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 1997, 91:605-615.
25. 25 Kuemmel TA, Thiele J, Schroeder R, Stoffel W: Pathology of visceral organs and bone marrow in an acid sphingomyelinase deficient knock-out mouse line, mimicking human Niemann-Pick disease type A: a light and electron microscopic study. Pathol Res Pract 1997, 193:663-671.
26. 26 Miranda SRP, Erlich S, Friedrick VL Jr, Haskins ME, Gatt S, Schuchman EH: Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells in acid sphingomyelinase-deficient mice. Transplantation 1998, 65:884-892. Acid sphingomyelinase-deficient knockout mice are improved by bone marrow transplantation administered following a sublethal dose of total body irradiation.
27. 27 Loftus SK, Morris JA, Carstea ED, Cummings C, Brown A, Ellison J, et al.: Murine model of Niemann-Pick disease: mutation in cholesterol homeostasis gene. Science 1997, 277:232-235.
28. 28 Somers KL, Wenger DA, Royals MA, Carstea ED, Connally HE, Kelly T, et al.: Complementation studies in human and feline Niemann-Pick type C disease. Mol Genet Metab 1999, 66:117-121.
29. 29 Suresh S, Yan Z, Patel RC, Patel YC, Patel SC: Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. J Neurochem 1998, 70:242-251. A blockade in apolipoprotein D release from astrocytes in NP-C is described and correlated with the appearance of neurofibrillary tangles in this disease.
30. 30 Schedin S, Pentchev P, Dallner G: Reduced cholesterol accumulation and improved deficient peroxisomal functions in a murine model of Niemann-Pick type C disease upon treatment with peroxisomal proliferators. Biochem Pharmacol 1998, 56:1195-1199. An improvement in peroxisomal function in NP-C could potentially alleviate this disease.
31. 31 Cerneca F, Andolina M, Simeone R, Boscolo R, Ciana G, Bemli B: Treatment of patients with Niemann-Pick type is using repeated amniotic epithelial cell implantation: correction of aggregation and coagulation abnormalities. Clin Pediatr 1997, 36:147-148.
32. 32 Blandergroen BA, Beynen AL, Geelen MJ: Dietary pectin lowers sphingomyelin concentration in VLDL and raises hepatic sphingomyelinase activity in rats. J Nutr 1999, 129:628-633.